Which has stronger earnings and valuation, QGEN or ILMN?

Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Qiagen $2.09B 4.17 $424.88M $1.91 22.13 Illumina $4.34B 6.54 $850M $5.36 35.07

Is QGEN or ILMN more profitable?

Qiagen has a net margin of 19.49% compared to Illumina's net margin of 18.36%. Illumina's return on equity of 29.84% beat Qiagen's return on equity. Company Net Margins Return on Equity Return on Assets Qiagen 19.49% 14.24% 8.23% Illumina 18.36% 29.84% 12.17%

Does the media favor QGEN or ILMN?

In the previous week, Illumina had 23 more articles in the media than Qiagen. MarketBeat recorded 44 mentions for Illumina and 21 mentions for Qiagen. Illumina's average media sentiment score of 0.82 beat Qiagen's score of 0.77 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 8 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 22 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer QGEN or MTD?

In the previous week, Mettler-Toledo International had 14 more articles in the media than Qiagen. MarketBeat recorded 35 mentions for Mettler-Toledo International and 21 mentions for Qiagen. Qiagen's average media sentiment score of 0.77 beat Mettler-Toledo International's score of 0.71 indicating that Qiagen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 8 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 15 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, MEDP or QGEN?

Medpace has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.53B 6.52 $451.12M $17.06 34.62 Qiagen $2.09B 4.17 $424.88M $1.91 22.13

Is MEDP or QGEN more profitable?

Qiagen has a net margin of 19.49% compared to Medpace's net margin of 17.67%. Medpace's return on equity of 110.15% beat Qiagen's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.67% 110.15% 24.84% Qiagen 19.49% 14.24% 8.23%

Does the media prefer MEDP or QGEN?

In the previous week, Qiagen had 11 more articles in the media than Medpace. MarketBeat recorded 21 mentions for Qiagen and 10 mentions for Medpace. Medpace's average media sentiment score of 1.47 beat Qiagen's score of 0.77 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Qiagen 8 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, QGEN or RVTY?

Qiagen has higher earnings, but lower revenue than Revvity. Qiagen is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Qiagen $2.09B 4.17 $424.88M $1.91 22.13 Revvity $2.86B 4.48 $241.20M $2.10 54.67

Is QGEN or RVTY more profitable?

Qiagen has a net margin of 19.49% compared to Revvity's net margin of 8.16%. Qiagen's return on equity of 14.24% beat Revvity's return on equity. Company Net Margins Return on Equity Return on Assets Qiagen 19.49% 14.24% 8.23% Revvity 8.16% 8.34% 5.01%

Does the media prefer QGEN or RVTY?

In the previous week, Revvity had 1 more articles in the media than Qiagen. MarketBeat recorded 22 mentions for Revvity and 21 mentions for Qiagen. Revvity's average media sentiment score of 0.90 beat Qiagen's score of 0.77 indicating that Revvity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 8 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revvity 9 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, QGEN or ICLR?

Qiagen has higher earnings, but lower revenue than Icon. Qiagen is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Qiagen $2.09B 4.17 $424.88M $1.91 22.13 Icon $8.25B 1.53 $229.34M $4.26 38.62

Is QGEN or ICLR more profitable?

Qiagen has a net margin of 19.49% compared to Icon's net margin of 3.99%. Qiagen's return on equity of 14.24% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Qiagen 19.49% 14.24% 8.23% Icon 3.99% 8.02% 4.56%

Does the media prefer QGEN or ICLR?

In the previous week, Qiagen had 6 more articles in the media than Icon. MarketBeat recorded 21 mentions for Qiagen and 15 mentions for Icon. Icon's average media sentiment score of 0.94 beat Qiagen's score of 0.77 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 8 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 9 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Qiagen (QGEN) Competitors

$42.28 +0.55 (+1.31%)

Closing price 03:59 PM Eastern

Extended Trading

$42.30 +0.02 (+0.05%)

As of 04:10 PM Eastern

Compare

QGEN vs. ILMN, MTD, MEDP, RVTY, and ICLR

Should you buy Qiagen stock or one of its competitors? MarketBeat compares Qiagen with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Qiagen include Illumina (ILMN), Mettler-Toledo International (MTD), Medpace (MEDP), Revvity (RVTY), and Icon (ICLR). These companies are all part of the "life sciences tools & services" industry.

How does Qiagen compare to Illumina?

Qiagen (NYSE:QGEN) and Illumina (NASDAQ:ILMN) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

Qiagen has a beta of 0.63, indicating that its share price is 37% less volatile than the broader market. Comparatively, Illumina has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market.

70.0% of Qiagen shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 9.0% of Qiagen shares are held by insiders. Comparatively, 2.9% of Illumina shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Illumina had 23 more articles in the media than Qiagen. MarketBeat recorded 44 mentions for Illumina and 21 mentions for Qiagen. Illumina's average media sentiment score of 0.82 beat Qiagen's score of 0.77 indicating that Illumina is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	22 Very Positive mention(s)	5 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Qiagen has a net margin of 19.49% compared to Illumina's net margin of 18.36%. Illumina's return on equity of 29.84% beat Qiagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	19.49%	14.24%	8.23%
Illumina	18.36%	29.84%	12.17%

Illumina has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$2.09B	4.17	$424.88M	$1.91	22.13
Illumina	$4.34B	6.54	$850M	$5.36	35.07

Qiagen currently has a consensus price target of $43.34, suggesting a potential upside of 2.52%. Illumina has a consensus price target of $188.40, suggesting a potential upside of 0.23%. Given Qiagen's higher probable upside, equities research analysts plainly believe Qiagen is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.36
Illumina	2 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.47

Summary

Illumina beats Qiagen on 13 of the 16 factors compared between the two stocks.

How does Qiagen compare to Mettler-Toledo International?

Qiagen (NYSE:QGEN) and Mettler-Toledo International (NYSE:MTD) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

In the previous week, Mettler-Toledo International had 14 more articles in the media than Qiagen. MarketBeat recorded 35 mentions for Mettler-Toledo International and 21 mentions for Qiagen. Qiagen's average media sentiment score of 0.77 beat Mettler-Toledo International's score of 0.71 indicating that Qiagen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	15 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Qiagen presently has a consensus price target of $43.34, indicating a potential upside of 2.52%. Mettler-Toledo International has a consensus price target of $1,461.27, indicating a potential upside of 2.25%. Given Qiagen's higher probable upside, research analysts plainly believe Qiagen is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.36
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Qiagen has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market.

Mettler-Toledo International has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$2.09B	4.17	$424.88M	$1.91	22.13
Mettler-Toledo International	$4.03B	7.11	$869.19M	$44.43	32.17

70.0% of Qiagen shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 9.0% of Qiagen shares are held by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Mettler-Toledo International has a net margin of 21.91% compared to Qiagen's net margin of 19.49%. Qiagen's return on equity of 14.24% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	19.49%	14.24%	8.23%
Mettler-Toledo International	21.91%	-1,212.14%	25.11%

Summary

Mettler-Toledo International beats Qiagen on 12 of the 17 factors compared between the two stocks.

How does Qiagen compare to Medpace?

Medpace (NASDAQ:MEDP) and Qiagen (NYSE:QGEN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership.

Medpace presently has a consensus target price of $584.18, indicating a potential downside of 1.10%. Qiagen has a consensus target price of $43.34, indicating a potential upside of 2.52%. Given Qiagen's stronger consensus rating and higher probable upside, analysts plainly believe Qiagen is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	11 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.15
Qiagen	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.36

Medpace has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.52	$451.12M	$17.06	34.62
Qiagen	$2.09B	4.17	$424.88M	$1.91	22.13

78.0% of Medpace shares are owned by institutional investors. Comparatively, 70.0% of Qiagen shares are owned by institutional investors. 20.5% of Medpace shares are owned by insiders. Comparatively, 9.0% of Qiagen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Qiagen has a net margin of 19.49% compared to Medpace's net margin of 17.67%. Medpace's return on equity of 110.15% beat Qiagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.67%	110.15%	24.84%
Qiagen	19.49%	14.24%	8.23%

In the previous week, Qiagen had 11 more articles in the media than Medpace. MarketBeat recorded 21 mentions for Qiagen and 10 mentions for Medpace. Medpace's average media sentiment score of 1.47 beat Qiagen's score of 0.77 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Qiagen	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medpace has a beta of 1.15, meaning that its share price is 15% more volatile than the broader market. Comparatively, Qiagen has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

Summary

Medpace beats Qiagen on 11 of the 17 factors compared between the two stocks.

How does Qiagen compare to Revvity?

Qiagen (NYSE:QGEN) and Revvity (NYSE:RVTY) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

In the previous week, Revvity had 1 more articles in the media than Qiagen. MarketBeat recorded 22 mentions for Revvity and 21 mentions for Qiagen. Revvity's average media sentiment score of 0.90 beat Qiagen's score of 0.77 indicating that Revvity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Revvity	9 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Qiagen presently has a consensus price target of $43.34, suggesting a potential upside of 2.52%. Revvity has a consensus price target of $108.36, suggesting a potential downside of 5.61%. Given Qiagen's stronger consensus rating and higher probable upside, analysts clearly believe Qiagen is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.36
Revvity	0 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.20

Qiagen pays an annual dividend of $0.35 per share and has a dividend yield of 0.8%. Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.2%. Qiagen pays out 18.3% of its earnings in the form of a dividend. Revvity pays out 13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Qiagen has higher earnings, but lower revenue than Revvity. Qiagen is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$2.09B	4.17	$424.88M	$1.91	22.13
Revvity	$2.86B	4.48	$241.20M	$2.10	54.67

Qiagen has a net margin of 19.49% compared to Revvity's net margin of 8.16%. Qiagen's return on equity of 14.24% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	19.49%	14.24%	8.23%
Revvity	8.16%	8.34%	5.01%

Qiagen has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Revvity has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market.

70.0% of Qiagen shares are held by institutional investors. Comparatively, 86.7% of Revvity shares are held by institutional investors. 9.0% of Qiagen shares are held by company insiders. Comparatively, 0.9% of Revvity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Qiagen beats Revvity on 10 of the 19 factors compared between the two stocks.

How does Qiagen compare to Icon?

Qiagen (NYSE:QGEN) and Icon (NASDAQ:ICLR) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Qiagen has a net margin of 19.49% compared to Icon's net margin of 3.99%. Qiagen's return on equity of 14.24% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	19.49%	14.24%	8.23%
Icon	3.99%	8.02%	4.56%

70.0% of Qiagen shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 9.0% of Qiagen shares are owned by insiders. Comparatively, 44.0% of Icon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Qiagen has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market. Comparatively, Icon has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

In the previous week, Qiagen had 6 more articles in the media than Icon. MarketBeat recorded 21 mentions for Qiagen and 15 mentions for Icon. Icon's average media sentiment score of 0.94 beat Qiagen's score of 0.77 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Icon	9 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Qiagen presently has a consensus price target of $43.34, indicating a potential upside of 2.52%. Icon has a consensus price target of $170.40, indicating a potential upside of 3.58%. Given Icon's stronger consensus rating and higher probable upside, analysts clearly believe Icon is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.36
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41

Qiagen has higher earnings, but lower revenue than Icon. Qiagen is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$2.09B	4.17	$424.88M	$1.91	22.13
Icon	$8.25B	1.53	$229.34M	$4.26	38.62

Summary

Icon beats Qiagen on 10 of the 16 factors compared between the two stocks.

Get Qiagen News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QGEN vs. The Competition

Export

Metric	Qiagen	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$8.71B	$9.41B	$6.98B	$24.08B
Dividend Yield	0.83%	1.46%	2.59%	3.70%
P/E Ratio	21.66	62.88	270.86	30.37
Price / Sales	4.17	106.23	662.75	13.03
Price / Cash	12.32	26.07	71.89	33.22
Price / Book	2.36	38.46	13.24	6.88
Net Income	$424.88M	$56.66B	$3.45B	$1.06B
7 Day Performance	1.73%	5.27%	4.62%	2.89%
1 Month Performance	9.01%	1.05%	-1.59%	2.54%
1 Year Performance	-16.88%	21.93%	77.38%	20.36%

Qiagen Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QGEN Qiagen	3.7953 of 5 stars	$42.28 +1.3%	$43.34 +2.5%	-16.5%	$8.71B	$2.09B	21.66	5,654	News Coverage Earnings Report Analyst Forecast
ILMN Illumina	2.7406 of 5 stars	$198.16 -3.4%	$188.40 -4.9%	+105.1%	$31.03B	$4.34B	36.97	8,650	Trending News Analyst Downgrade Insider Trade
MTD Mettler-Toledo International	3.0046 of 5 stars	$1,446.84 +2.2%	$1,445.36 -0.1%	+16.3%	$28.62B	$4.03B	32.56	18,100	Earnings Report Analyst Forecast Insider Trade
MEDP Medpace	2.9074 of 5 stars	$573.29 -0.7%	$584.18 +1.9%	+35.9%	$16.11B	$2.53B	33.60	6,200	Positive News
RVTY Revvity	2.85 of 5 stars	$115.21 +2.4%	$108.36 -5.9%	+33.3%	$12.55B	$2.86B	55.12	11,000	Earnings Report Dividend Announcement Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:QGEN) was last updated on 8/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Qiagen (QGEN) Competitors